This site is intended for health professionals only

Published on 15 April 2016

Share this story:
Twitter
LinkedIn

Martindale Pharma launches first ready-to-use presentation of Phenylephrine

Martindale Pharma, the UK-based leading international specialty pharmaceutical company, announced the UK launch of Phenylephrine, a new strength of the selective vasopressor drug for the treatment of hypotension associated with anaesthesia. Phenylephrine will be available in a 10ml ampoule at a strength of 0.1mg/ml.

Martindale Pharma, the UK-based leading international specialty pharmaceutical company, announced the UK launch of Phenylephrine, a new strength of the selective vasopressor drug for the treatment of hypotension associated with anaesthesia. Phenylephrine will be available in a 10ml ampoule at a strength of 0.1mg/ml.

This new strength not only allows for accurate dose dispensing but also provides healthcare professionals with a much needed replacement to using the concentrated alternative. To date Phenylephrine is only available as a 10mg/ml in 1ml ampoules, which is diluted prior to use. Martindale Pharma’s Phenylephrine product offers a simpler approach to product use, and can be given as an intravenous bolus injection or as a continuous infusion without the need for dilution.

Martindale Pharma has licensed exclusive rights to a range of Phenylephrine products for the UK and Gulf Co-Operation Council Countries from Unimedic AB, Martindale Pharma’s strategic partner for Scandinavia. This particular product joins the range of cardiovascular drugs within Martindale Pharma’s Emergency Care portfolio.

Michael Clark, Chief Marketing Officer of Martindale Pharma, commented: “We are pleased with this positive addition to this well-known Phenylephrine range. Our novel presentation removes the need to dilute the drug prior to use allowing for more accurate dose dispensing resulting in both time and cost savings for the NHS. Our NHS price is also significantly lower than the “concentrate” product.

The launch of this ready-to-use product demonstrates Martindale Pharma commitment to providing high quality innovative products to our customers and to patients while ensuring cost-effectiveness for the NHS.

For further information on these products please contact customer services on 0800 0287933 or at connect@martindalepharma.co.uk, or for medical enquiries please contact medical information at medinfo@martindalepharma.co.uk.

View the Summary of Product Characteristics
https://www.medicines.org.uk/emc/medicine/31686



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn